GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » EV-to-Revenue

Novartis India (BOM:500672) EV-to-Revenue : 6.35 (As of Jun. 21, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Novartis India's enterprise value is ₹21,278 Mil. Novartis India's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹3,351 Mil. Therefore, Novartis India's EV-to-Revenue for today is 6.35.

The historical rank and industry rank for Novartis India's EV-to-Revenue or its related term are showing as below:

BOM:500672' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.09   Med: 2.8   Max: 7.75
Current: 6.36

During the past 13 years, the highest EV-to-Revenue of Novartis India was 7.75. The lowest was 1.09. And the median was 2.80.

BOM:500672's EV-to-Revenue is ranked worse than
82.2% of 1017 companies
in the Drug Manufacturers industry
Industry Median: 2.21 vs BOM:500672: 6.36

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-21), Novartis India's stock price is ₹1100.70. Novartis India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹135.70. Therefore, Novartis India's PS Ratio for today is 8.11.


Novartis India EV-to-Revenue Historical Data

The historical data trend for Novartis India's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India EV-to-Revenue Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.77 2.54 2.49 2.28 5.82

Novartis India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.28 5.74 3.93 5.78 5.82

Competitive Comparison of Novartis India's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis India's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis India's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Novartis India's EV-to-Revenue falls into.



Novartis India EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Novartis India's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=21277.960/3350.7
=6.35

Novartis India's current Enterprise Value is ₹21,278 Mil.
Novartis India's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,351 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis India  (BOM:500672) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Novartis India's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1100.70/135.701
=8.11

Novartis India's share price for today is ₹1100.70.
Novartis India's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹135.70.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis India EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Novartis India's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis India (BOM:500672) Business Description

Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines